study had no recorded clopidogrel use within 7 days of hospital discharge.1 We believe the primary cause of the low use of clopidogrel is the fact that the study covered the period between 200
Contains fulltext : 88128.pdf (publisher's version ) (Closed access)OBJECTIVES: Re...
Copyright © 2012 Francesca Macaione et al. This is an open access article distributed under the Crea...
We read with interest the article by Mora and colleagues,1 who are well supported when stating that ...
We thank Drs Ford and Plachetka for their interest in our article.1 We agree that other unmeasured f...
patients undergoing elective percutaneous coronary intervention To the Editor We read with interest ...
As noted by Dr Aboyans and colleagues, no interaction was noted in the effect of clopidogrel versus ...
As noted by Dr Aboyans and colleagues, no interaction was noted in the effect of clopidogrel versus ...
Berger and colleagues1 are commended for their interesting and hypothesis-generating posthoc analysi...
OBJECTIVES: We sought to compare the 1-year risk of re-hospitalization for acute coronary syndrome (...
I read with interest the article by Mahoney et al1 suggesting the cost advantage of prasugrel over c...
The recent article by Karabulut et al. [1] on use of clopidogrel before coronary artery surgery addr...
We thank Niccoli et al for their letter, which interestingly suggested that intracoronary administra...
ObjectivesWe studied the association of clopidogrel with mortality in acute myocardial infarction (A...
In a prospective study performed in 700 patients undergoing percutaneous coronary intervention, Frel...
In a retrospective, nonrandomized subanalysis of the single-center REMADHE trial, Issa et al1 sugges...
Contains fulltext : 88128.pdf (publisher's version ) (Closed access)OBJECTIVES: Re...
Copyright © 2012 Francesca Macaione et al. This is an open access article distributed under the Crea...
We read with interest the article by Mora and colleagues,1 who are well supported when stating that ...
We thank Drs Ford and Plachetka for their interest in our article.1 We agree that other unmeasured f...
patients undergoing elective percutaneous coronary intervention To the Editor We read with interest ...
As noted by Dr Aboyans and colleagues, no interaction was noted in the effect of clopidogrel versus ...
As noted by Dr Aboyans and colleagues, no interaction was noted in the effect of clopidogrel versus ...
Berger and colleagues1 are commended for their interesting and hypothesis-generating posthoc analysi...
OBJECTIVES: We sought to compare the 1-year risk of re-hospitalization for acute coronary syndrome (...
I read with interest the article by Mahoney et al1 suggesting the cost advantage of prasugrel over c...
The recent article by Karabulut et al. [1] on use of clopidogrel before coronary artery surgery addr...
We thank Niccoli et al for their letter, which interestingly suggested that intracoronary administra...
ObjectivesWe studied the association of clopidogrel with mortality in acute myocardial infarction (A...
In a prospective study performed in 700 patients undergoing percutaneous coronary intervention, Frel...
In a retrospective, nonrandomized subanalysis of the single-center REMADHE trial, Issa et al1 sugges...
Contains fulltext : 88128.pdf (publisher's version ) (Closed access)OBJECTIVES: Re...
Copyright © 2012 Francesca Macaione et al. This is an open access article distributed under the Crea...
We read with interest the article by Mora and colleagues,1 who are well supported when stating that ...